Trading Window to Close Ahead of September Quarter Results
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kwality Pharmaceuticals has informed BSE that the trading window for dealing in its equity shares will remain closed from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half-year ended September 30, 2026. The closure applies to all designated persons and their immediate relatives under SEBI's insider trading regulations and the company's code of conduct. The date of the board meeting to consider and declare these results will be announced separately.
Routine compliance intimation. No insider buy or sell activity disclosed. Investors await the Q2 FY27 results and board meeting date.